Development Process

CeloNova can quickly mobilize a team to bring a product to market in a timely manner. In June 2004, embolic microspheres utilizing Polyzene®-F were a concept; there were no embolization products that had been uniquely conceptualized and created specifically for this use.

There were several barriers to production:

• Creating a perfectly spherical hydrogel core
• Applying the Polyzene^®-F superstrate
• Perfecting the transport solution
• Assuring buoyancy of the microspheres
• Computerized microscopic calibration.

Research and development began later that year, in Winter 2004. The first step was to conduct interviews with physicians about the features they wanted and needed. The company also began initial development experiments.

With typical dedication to solving problems, CeloNova received its CE Mark approval in November 2005. The product met the company’s goals and offered the following convenient features for physicians:

• No clumping in microcatheter or clogging at the syringe hub
• Easy to inject, slowly or quickly
• Fast and long-lasting suspension
• Available in vials and syringes

::: See the Features
::: Download the Brochure
::: Download Syringe Preparation Procedure
::: Download Contrast Media Mixing Chart